Close
ACHEMA MIDDLE EAST 2026

European Union approves Alprolix (rFIXFc) for the Treatment of Haemophilia B

Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, for the treatment of...

European Union approves Alprolix (rFIXFc) for the Treatment of Haemophilia B

Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, for the treatment of...

AbbVie Inc to participate at the UBS Global Health Care Conference

AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and chief financial officer, will...

Merck Showcases New Innovations at Analytica 2016

Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for...

Merck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers

   • Detects biomarkers of horse infection, inflammation, immune response and general health   • Addresses unmet needs of equine research centers, veterinary research and...

Pfizer Gets Europe Approval For New Multi-Dose Vial Vaccine

fizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved a new four-dose, multi-dose...

AstraZeneca completes divestment of Imdur to China Medical System Holdings

AstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical System Holdings Ltd and...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...